13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001493215
申报总市值
US$117.1亿
US$117.1亿
69 檔
16.0%
在 Q1 2024 申报期间，Rtw Investments, LP（CIK: 0001493215）向美国 SEC 提交的 Form 13F 报告显示，其追踪之股票投资组合总市值达 US$117.1亿，共持有 69 个公开申报仓位。
在 Q1 2024，Rtw Investments, LP 操作展现出积极扩展与加仓意向。本季共新建仓 9 个新仓位，并对 20 个既有持股进行加仓（合计增持 29 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Rtw Investments, LP 的前 5 大核心持股（包含 RCKT, IMCR, AXSM 等）合计占整体申报市值的 16.0%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RCKT | Rocket Pharmaceuticals Inc | 股票-其他 | 7.03% | -0.11% | — | |
| 2 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 5.78% | -0.14% | -1.26% | |
| 3 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 5.29% | — | +0.07% | |
| 4 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 4.88% | +1.46% | +2.90% | |
| 5 | BRKR | Bruker CORP | 股票-医疗保健 | 4.64% | — | — | |
| 6 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 3.88% | +0.46% | — | |
| 7 | ACAD | Acadia Pharmaceuticals Inc | 股票-医疗保健 | 3.77% | -0.04% | +22.89% | |
| 8 | NTRA | Natera Inc | 股票-医疗保健 | 3.50% | -0.17% | — | |
| 9 | PTCT | Ptc Therapeutics Inc | 股票-医疗保健 | 3.19% | +0.14% | — | |
| 10 | MASI* | Masimo CORP | 股票-其他 | 3.17% | — | — | |
| 11 | RNAGBP | Avidity Biosciences Inc | 股票-其他 | 3.00% | — | +19.14% | |
| 12 | ✓ | Merus N V | 股票-其他 | 2.73% | — | +73.13% | |
| 13 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 2.61% | +0.30% | — | |
| 14 | APGE | Apogee Therapeutics Inc | 股票-其他 | 2.42% | -2.33% | EXIT | |
| 15 | ALKS | Alkermes plc | 股票-医疗保健 | 2.42% | +0.16% | +55.18% | |
| 16 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 2.27% | -0.01% | — | |
| 17 | PEN | Penumbra Inc | 股票-医疗保健 | 2.23% | — | +2.00% | |
| 18 | ✓ | Avadel Pharmaceuticals PLC ADR | 股票-其他 | 2.19% | — | +26.64% | |
| 19 | AKRO | Akero Therapeutics Inc | 股票-其他 | 2.03% | — | +51.19% | |
| 20 | ✓ | Establishment Labs Holdings In | 股票-其他 | 2.01% | +0.45% | +7.28% | |
| 21 | ARVN | Arvinas Inc | 股票-其他 | 2.01% | — | -21.73% | |
| 22 | TARS | Tarsus Pharmaceuticals Inc | 股票-其他 | 1.76% | -0.54% | +3.81% | |
| 23 | SYK | Stryker CORP | 股票-医疗保健 | 1.70% | -0.33% | EXIT | |
| 24 | MDGL | Madrigal Pharmaceuticals Inc | 股票-医疗保健 | 1.57% | -1.24% | -51.29% | |
| 25 | ✓ | Immatics NV | 股票-其他 | 1.55% | -0.14% | +573.44% | |
| 26 | SG7 | Sage Therapeutics Inc | 股票-其他 | 1.52% | — | +5.46% | |
| 27 | SWAVUSD | Shockwave Medical Inc | 股票-其他 | 1.39% | — | +343.72% | |
| 28 | DYN | Dyne Therapeutics Inc | 股票-其他 | 1.30% | — | — | |
| 29 | ETNBGBP | 89bio Inc | 股票-其他 | 1.27% | — | +32.26% | |
| 30 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.25% | +1.13% | — | |
| 31 | VCEL | Vericel CORP | 股票-其他 | 1.23% | — | -50.00% | |
| 32 | CRGX | Cargo Therapeutics Inc | 股票-其他 | 1.23% | — | -27.83% | |
| 33 | RDNT | Radnet Inc | 股票-医疗保健 | 1.22% | +0.17% | +156.26% | |
| 34 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 0.95% | — | +121.00% | |
| 35 | TXG | 10x Genomics Inc-class A | 股票-其他 | 0.86% | — | +0.32% | |
| 36 | STOK | Stoke Therapeutics Inc | 股票-其他 | 0.84% | -0.25% | +2.27% | |
| 37 | FULC | Fulcrum Therapeutics Inc | 股票-其他 | 0.81% | — | +6.87% | |
| 38 | TSHA | Taysha Gene Therapies Inc | 股票-其他 | 0.79% | +0.18% | +10.06% | |
| 39 | INSM | Insmed Inc | 股票-医疗保健 | 0.75% | -3.47% | — | |
| 40 | URGN | UroGen Pharma Ltd. | 股票-其他 | 0.72% | +0.62% | +88.63% | |
| 41 | KYTX | Kyverna Therapeutics Inc | 股票-其他 | 0.68% | — | — | |
| 42 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 0.58% | -1.01% | EXIT | |
| 43 | NGNE | Neurogene Inc | 股票-其他 | 0.58% | +0.10% | — | |
| 44 | JANX | Janux Therapeutics Inc | 股票-其他 | 0.56% | — | — | |
| 45 | GHRS | GH Research PLC | 股票-其他 | 0.52% | +0.53% | — | |
| 46 | OBIO | Orchestra Biomed Holdings In | 股票-其他 | 0.44% | — | — | |
| 47 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 0.30% | — | — | |
| 48 | EPIEUR | Essa Pharma Inc | 股票-其他 | 0.29% | — | — | |
| 49 | LENZ | Lenz Therapeutics Inc | 股票-其他 | 0.28% | — | — | |
| 50 | CGON | Cg Oncology Inc | 股票-其他 | 0.27% | +0.46% | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | RNAGBP | Avidity Biosciences Inc | +2.1% | +19.14% | 加仓 |
| 2 | ✓ | Merus N V | +1.7% | +73.13% | 加仓 |
| 3 | SYK | Stryker CORP | +1.7% | NEW | 新建仓 |
| 4 | APGE | Apogee Therapeutics Inc | +1.5% | +15.17% | 加仓 |
| 5 | ✓ | Immatics NV | +1.3% | +573.44% | 加仓 |
| 6 | DYN | Dyne Therapeutics Inc | +1.3% | NEW | 新建仓 |
| 7 | SWAVUSD | Shockwave Medical Inc | +1.2% | +343.72% | 加仓 |
| 8 | ✓ | Establishment Labs Holdings In | +1% | +7.28% | 加仓 |
| 9 | NTRA | Natera Inc | +1% | — | 不变 |
| 10 | RDNT | Radnet Inc | +0.9% | +156.26% | 加仓 |
| 11 | BRKR | Bruker CORP | +0.8% | — | 不变 |
| 12 | TARS | Tarsus Pharmaceuticals Inc | +0.8% | +3.81% | 加仓 |
| 13 | ALKS | Alkermes plc | +0.7% | +55.18% | 加仓 |
| 14 | AKRO | Akero Therapeutics Inc | +0.7% | +51.19% | 加仓 |
| 15 | KYTX | Kyverna Therapeutics Inc | +0.7% | NEW | 新建仓 |
| 16 | ✓ | Avadel Pharmaceuticals PLC ADR | +0.7% | +26.64% | 加仓 |
| 17 | ISRG | Intuitive Surgical Inc | +0.6% | NEW | 新建仓 |
| 18 | NGNE | Neurogene Inc | +0.6% | NEW | 新建仓 |
| 19 | JANX | Janux Therapeutics Inc | +0.6% | NEW | 新建仓 |
| 20 | TMO | Thermo Fisher Scientific Inc | +0.5% | +121.00% | 加仓 |
| 21 | SYRE | Spyre Therapeutics Inc | +0.5% | — | 不变 |
| 22 | STOK | Stoke Therapeutics Inc | +0.5% | +2.27% | 加仓 |
| 23 | MASI* | Masimo CORP | +0.5% | — | 不变 |
| 24 | PTGX | Protagonist Therapeutics Inc | +0.4% | — | 不变 |
| 25 | TSHA | Taysha Gene Therapies Inc | +0.3% | +10.06% | 加仓 |
| 26 | URGN | UroGen Pharma Ltd. | +0.3% | +88.63% | 加仓 |
| 27 | ETNBGBP | 89bio Inc | +0.3% | +32.26% | 加仓 |
| 28 | DNTH | Dianthus Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 29 | LENZ | Lenz Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 30 | CGON | Cg Oncology Inc | +0.3% | NEW | 新建仓 |
| 31 | FULC | Fulcrum Therapeutics Inc | +0.2% | +6.87% | 加仓 |
| 32 | GHRS | GH Research PLC | +0.2% | — | 不变 |
| 33 | GH | Guardant Health Inc | -0.2% | EXIT | 清仓 |
| 34 | TNGX | Tango Therapeutics Inc | -0.3% | EXIT | 清仓 |
| 35 | SWTXUSD | Springworks Therapeutics Inc | -0.4% | EXIT | 清仓 |
| 36 | OBIO | Orchestra Biomed Holdings In | -0.4% | — | 不变 |
| 37 | PEN | Penumbra Inc | -0.4% | +2.00% | 加仓 |
| 38 | DHR | Danaher CORP | -0.4% | EXIT | 清仓 |
| 39 | TXG | 10x Genomics Inc-class A | -0.5% | +0.32% | 加仓 |
| 40 | VCEL | Vericel CORP | -0.6% | -50.00% | 减仓 |
| 41 | CRGX | Cargo Therapeutics Inc | -0.6% | -27.83% | 减仓 |
| 42 | CYTK | Cytokinetics Inc | -0.7% | — | 不变 |
| 43 | ARVN | Arvinas Inc | -0.7% | -21.73% | 减仓 |
| 44 | IMCR | Immunocore Holdings Plc-adr | -0.7% | -1.26% | 减仓 |
| 45 | RCKT | Rocket Pharmaceuticals Inc | -1.3% | — | 不变 |
| 46 | MDGL | Madrigal Pharmaceuticals Inc | -1.4% | -51.29% | 减仓 |
| 47 | ACAD | Acadia Pharmaceuticals Inc | -1.7% | +22.89% | 加仓 |
| 48 | CLDX | Celldex Therapeutics Inc | -2.2% | EXIT | 清仓 |
| 49 | ALNY | Alnylam Pharmaceuticals Inc | -4.9% | EXIT | 清仓 |
| 50 | MRTXEUR | Mirati Therapeutics Inc | -6.2% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Rtw Investments, LP 在 Q1 2024 季度的美股持仓总市值约为 US$117.1亿，共申报了 69 个公开持股仓位。
在 Q1 2024 季度，Rtw Investments, LP 按市值排列的前三大核心持股分别为：RCKT (7.0%)、IMCR (5.8%)、AXSM (5.3%)。其中最大持股仓位 RCKT 占据整体投资组合约 7.0% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
SYK
市值: US$1.1亿
本季最大获利了结 / 清仓标的
MRTXEUR
前期市值: US$4.0亿
在 Q1 2024 季度中，Rtw Investments, LP 共进行了 41 项持仓异动，包含新建仓 9 个仓位、加仓 20 个仓位、减仓 5 个仓位以及清仓 7 个仓位。 其中最大新建仓标的为 SYK。 本季清仓仓位包含 MRTXEUR。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。